Iqvia Holdings Inc.

Company facts

Industry

Services-Commercial Physical & Biological Research

Headquarters

Durham, North Carolina

Most recent report

10-Q, filed Jul 28, 2026

Incorporated

Delaware

Filings on record

1,001+ filings

On EDGAR

CIK 1478242

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 2 of 11 sections worth reading, with 2 positive, 6 notable, and 0 negative flags.

• Financial Statements (Item 1)

  Financial statements and notes contain key metrics: revenue, restructuring, debt, and buyback activity.
  Positive

  • Board increased stock repurchase authorization by $2,000 million in May 2026 to $15,725 million total.
  Notable

  • Remaining performance obligations were $36.4 billion as of June 30, 2026, down from $37.3 billion three months earlier.
  • Factored $367 million of receivables on a non-recourse basis in the first half of 2026, up from $330 million a year ago.
  • Issued €950 million of 4.625% senior notes due 2033; proceeds used to repay Term Loan due 2027 and revolver.
  • Effective tax rate rose to 19.9% in Q2 2026 from 17.3% in Q2 2025 due to mix of earnings.
  • Segment reporting reorganized from three segments to two effective January 1, 2026.

• Management's Discussion (Item 2)

  MD&A with specific quarterly results, segment data, and debt actions.
  Positive

  • Operating cash flow +$165M in H1 2026 vs prior year, driven by working capital.
  Notable

  • Interest expense rose to $197M Q2 and $389M H1 due to higher debt balances.

What changed: Jun 2026 vs. Mar 2026

About 9% of IQV's Jun 2026 10-Q is new information. 19 paragraphs were added, 110 changed, and 16 removed. Below are the most important lines SECSift identified.

• Item 2 45
• Item 1 38
• Item 5 1
• Item 6 1